Möchten Sie immer auf dem neuesten Stand bleiben?

MALVERN, Pa., May 05, 2026 (GLOBE NEWSWIRE) -- Ocugen, Inc. (“Ocugen”) (NASDAQ: OCGN) today announced the pricing of $115 million aggregate principal amount of 6.75% Convertible Senior Notes due...

Key findings from the DME AWARE initiative highlight the importance of non-invasive treatment options for early intervention in diabetic macular edema (DME) managementOculis is on track to report...

MALVERN, Pa., May 04, 2026 (GLOBE NEWSWIRE) -- Ocugen, Inc. (“Ocugen” or the “Company”) (NASDAQ: OCGN), a pioneering biotechnology leader in gene therapies for blindness diseases, today announced...

New BPEI preclinical data address treatment protocol, corneal biochemical environment, fungal resistance mechanism, MRSA biofilm inhibition, and enhanced cysticidal activity KNOXVILLE, Tenn., May ...

Latest findings from the DME AWARE Delphi Study on unmet needs in diabetic macular edema (DME) management highlighting the need for non-invasive therapeutic options to be presented by Baruch...

Alkeus Pharmaceuticals announces presentation of gildeuretinol data during Association for Research in Vision and Ophthalmology (ARVO) 2026 annual meeting

Franklin Park, Illinois, April 29, 2026 (GLOBE NEWSWIRE) -- Centurion Service Group, an industry-leading medical equipment lifecycle organization, in partnership with Auction Advisors, LLC, a...

Doheny Eye Institute will have more than 25 scientists, clinician-scientists, and research fellows presenting their latest research at ARVO 2026.

CE Mark under the European Union Medical Device Regulation (EU MDR) achieved for Virtuoso®, BVI’s first dual-function phaco-vitrectomy platform designed to deliver advanced control, efficiency, and...

Doheny Eye Institute named Yuhua Zhang, PhD, chairholder of the Carolyn and Chuck Miller Endowed Chair for Vision Research.